Acelrx Pharmaceuticals shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Acelrx Pharmaceuticals (TLPH) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Acelrx Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Acelrx Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Acelrx Pharmaceuticals by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $39 | 54 | 0.74 |
| 2023-09-30 | $22 | 39 | 0.59 |
| 2023-06-30 | $28 | 25 | 1.12 |
| 2023-03-31 | $0 | 175 | 0.00 |
| 2022-12-31 | $0 | 208 | 0.00 |